 The Risk Minimization Action Plans are set in place depending on the overall level of risk a prescription drug is likely to pose to the public.Prior to the 1990s, only 20% of all drugs prescribed for children in the United States were tested for safety or efficacy in a pediatric population.This became a major concern of pediatricians as evidence accumulated that the physiological response of children to many drugs differed significantly from those drugs' effects on adults.